GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » Sloan Ratio %

Dolby Laboratories (Dolby Laboratories) Sloan Ratio % : -5.36% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Dolby Laboratories Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Dolby Laboratories's Sloan Ratio for the quarter that ended in Dec. 2023 was -5.36%.

As of Dec. 2023, Dolby Laboratories has a Sloan Ratio of -5.36%, indicating the company is in the safe zone and there is no funny business with accruals.


Dolby Laboratories Sloan Ratio % Historical Data

The historical data trend for Dolby Laboratories's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dolby Laboratories Sloan Ratio % Chart

Dolby Laboratories Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.58 -8.46 -2.98 6.00 -7.40

Dolby Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.67 -5.13 -4.90 -7.40 -5.36

Competitive Comparison of Dolby Laboratories's Sloan Ratio %

For the Specialty Business Services subindustry, Dolby Laboratories's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dolby Laboratories's Sloan Ratio % Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Dolby Laboratories's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Dolby Laboratories's Sloan Ratio % falls into.



Dolby Laboratories Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Dolby Laboratories's Sloan Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Sloan Ratio=(Net Income (A: Sep. 2023 )-Cash Flow from Operations (A: Sep. 2023 )
-Cash Flow from Investing (A: Sep. 2023 ))/Total Assets (A: Sep. 2023 )
=(200.656-367.081
-54.206)/2979.766
=-7.40%

Dolby Laboratories's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(188.262-319.095
-26.539)/2935.529
=-5.36%

Dolby Laboratories's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 95.696 (Mar. 2023 ) + 16.399 (Jun. 2023 ) + 9.186 (Sep. 2023 ) + 66.981 (Dec. 2023 ) = $188 Mil.
Dolby Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 104.542 (Mar. 2023 ) + 121.129 (Jun. 2023 ) + 85.015 (Sep. 2023 ) + 8.409 (Dec. 2023 ) = $319 Mil.
Dolby Laboratories's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was 23.586 (Mar. 2023 ) + 22.031 (Jun. 2023 ) + -19.711 (Sep. 2023 ) + 0.633 (Dec. 2023 ) = $27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dolby Laboratories  (NYSE:DLB) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Dolby Laboratories has a Sloan Ratio of -5.36%, indicating the company is in the safe zone and there is no funny business with accruals.


Dolby Laboratories Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dolby Laboratories (Dolby Laboratories) Business Description

Traded in Other Exchanges
Address
1275 Market Street, San Francisco, CA, USA, 94103-1410
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Executives
Kevin J Yeaman officer: VP, Chief Financial Officer C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Mark Andrew Sherman officer: EVP, GEN. COUN. & SECRTY DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling officer: SVP, Entertainment C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton officer: SVP, Chief Marketing Officer 1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud director C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars director C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian director DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher director
Ryan Nicholson officer: VP, Corporate Controller C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar officer: SVP, Advanced Technology Group C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet director 9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park officer: SVP & Chief Financial Officer C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay officer: Sr. Vice President, Research 1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew officer: EVP, Chief Financial Officer DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103

Dolby Laboratories (Dolby Laboratories) Headlines